Population pharmacokinetics of ropivacaine used for local infiltration anaesthesia during primary total unilateral and simultaneous bilateral knee arthroplasty.

[1]  S. Grassin-Delyle,et al.  Validation according to European and American regulatory agencies guidelines of an LC-MS/MS method for the quantification of free and total ropivacaine in human plasma , 2019, Clinical chemistry and laboratory medicine.

[2]  Ken Johnson,et al.  Serum ropivacaine levels after local infiltration analgesia during total knee arthroplasty with and without adductor canal block , 2019, Regional Anesthesia & Pain Medicine.

[3]  O. Blin,et al.  Ropivacaine Wound Infiltration for Pain Management After Breast Cancer Mastectomy: A Population Pharmacokinetic Analysis , 2018, Clinical pharmacology in drug development.

[4]  D. Guerrot,et al.  Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia , 2018, Clinical Pharmacokinetics.

[5]  G. Scheffer,et al.  Pharmacokinetics of 400 mg Locally Infiltrated Ropivacaine After Total Knee Arthroplasty Without Perioperative Tourniquet Use , 2018, Regional Anesthesia & Pain Medicine.

[6]  G. Scheffer,et al.  Pharmacokinetics of 400 mg ropivacaine after periarticular local infiltration analgesia for total knee arthroplasty , 2017, Acta anaesthesiologica Scandinavica.

[7]  J. Attia,et al.  The efficacy of local infiltration analgesia in the early postoperative period after total knee arthroplasty: A systematic review and meta-analysis , 2016, European journal of anaesthesiology.

[8]  A. Atchabahian,et al.  Plasma concentrations of ropivacaine following ultrasound-guided or nerve-stimulator-guided femoral nerve block: A prospective randomised study. , 2016, Anaesthesia, critical care & pain medicine.

[9]  K. Gromov,et al.  Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting , 2016, Acta orthopaedica.

[10]  D. McDonald,et al.  Ropivacaine plasma levels following high‐dose local infiltration analgesia for total knee arthroplasty , 2015, Anaesthesia.

[11]  E. Ollier,et al.  Population pharmacokinetic model of free and total ropivacaine after transversus abdominis plane nerve block in patients undergoing liver resection. , 2015, British journal of clinical pharmacology.

[12]  H. Kehlet,et al.  Analgesic efficacy of local infiltration analgesia in hip and knee arthroplasty: a systematic review. , 2014, British journal of anaesthesia.

[13]  J. Barrett,et al.  Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: A Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization , 2013, Clinical Cancer Research.

[14]  H. Husted.  Fast-track hip and knee arthroplasty: clinical and organizational aspects , 2012, Acta orthopaedica. Supplementum.

[15]  P. Drolet,et al.  A population pharmacokinetic model for the complex systemic absorption of ropivacaine after femoral nerve block in patients undergoing knee surgery , 2012, Journal of Pharmacokinetics and Pharmacodynamics.

[16]  L. Aarons,et al.  Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children. , 2011, British journal of anaesthesia.

[17]  H. Kehlet,et al.  Local infiltration analgesia in joint replacement: the evidence and recommendations for clinical practice , 2011, Acta anaesthesiologica Scandinavica.

[18]  H. Kehlet,et al.  High‐volume infiltration analgesia in total knee arthroplasty: a randomized, double‐blind, placebo‐controlled trial , 2008, Acta anaesthesiologica Scandinavica.

[19]  G. Fanelli,et al.  Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. , 2008, Acta bio-medica : Atenei Parmensis.

[20]  N. Holford,et al.  Mechanism-based concepts of size and maturity in pharmacokinetics. , 2008, Annual review of pharmacology and toxicology.

[21]  Y. Kimura,et al.  Ropivacaine-induced toxicity with overdose suspected after axillary brachial plexus block , 2007, Journal of Anesthesia.

[22]  A. Ho,et al.  Arterial and Venous Pharmacokinetics of Ropivacaine with and without Epinephrine after Thoracic Paravertebral Block , 2005, Anesthesiology.

[23]  J. Motsch,et al.  Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block , 2004, Paediatric anaesthesia.

[24]  Lim,et al.  Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations , 2001, Paediatric anaesthesia.

[25]  K. Ilett,et al.  Caudal ropivacaine in infants: population pharmacokinetics and plasma concentrations , 2000, Anesthesiology.

[26]  A. Burm,et al.  Epidural Infusion of Ropivacaine for Postoperative Analgesia after Major Orthopedic Surgery: Pharmacokinetic Evaluation , 2000, Anesthesiology.

[27]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[28]  D. Scott,et al.  Pharmacokinetics and Efficacy of Long-Term Epidural Ropivacaine Infusion for Postoperative Analgesia , 1997, Anesthesia and analgesia.

[29]  K.,et al.  Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. , 1997, British journal of anaesthesia.

[30]  G. Tucker,et al.  Disposition Kinetics of Ropivacaine in Humans , 1989, Anesthesia and analgesia.

[31]  R Hume,et al.  Prediction of lean body mass from height and weight , 1966, Journal of clinical pathology.

[32]  P. Wretenberg,et al.  A randomized study comparing plasma concentration of ropivacaine after local infiltration analgesia and femoral block in primary total knee arthroplasty , 2012, Scandinavian journal of pain.

[33]  Stephen B. Duffull,et al.  Quantification of Lean Bodyweight , 2005, Clinical pharmacokinetics.

[34]  J. Mazoit,et al.  Pharmacokinetics of Local Anaesthetics in Infants and Children , 2004, Clinical pharmacokinetics.